Skip to main content
WuXi AppTec Co., Ltd. logo

WuXi AppTec Co., Ltd. — Investor Relations & Filings

Ticker · 2359 ISIN · CNE100003F19 LEI · 254900OEPQLZSPLN9175 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 1,743 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country CN China
Listing HKEX 2359

About WuXi AppTec Co., Ltd.

http://www.wuxiapptec.com.cn

WuXi AppTec Co., Ltd. is a global Contract Research, Development, and Manufacturing Organization (CRDMO) dedicated to enabling the pharmaceutical and life sciences industries. The company provides an integrated, open-access capability and technology platform to accelerate the discovery, development, and manufacturing of innovative therapies. Core services encompass a broad portfolio of R&D solutions, including discovery biology (hit finding, oncology services), analytical testing, and clinical research services. Utilizing its end-to-end CRDMO model, which includes specialized platforms like WuXi STA for pharmaceutical development and manufacturing, WuXi AppTec partners with clients globally to advance new medicines from concept through commercialization.

Recent filings

Filing Released Lang Actions
H股公告
Regulatory Filings
2026-06-01 Chinese
H股公告
Transaction in Own Shares Classification · 95% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Form (FF305) detailing changes in issued and treasury shares, including the specific share repurchase transaction and related authorization information under the HKEX Listing Rules. It is a regulatory disclosure of the company’s own share transactions (buy-backs and treasury holdings). This aligns directly with the “Transaction in Own Shares” category.
2026-05-27 Chinese
2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is a corporate announcement detailing the 2025 annual equity distribution (cash dividend) for A‐share holders, including per‐share dividend, record date, ex‐dividend date, payment date, and tax treatment for various investor categories. This matches the "Notice of Dividend Amount" category.
2026-05-22 Chinese
H股公告
Capital/Financing Update Classification · 95% confidence The document is a Hong Kong Exchange announcement regarding the completion of a RMB6,780 million zero‐coupon convertible bond issuance and describes proceeds usage, listing approvals, and regulatory filings. This is a financing activity update, not a full report or management discussion, and not merely a notice of publication. Therefore it falls under Capital/Financing Update (CAP).
2026-05-21 Chinese
H股公告
Capital/Financing Update Classification · 88% confidence The document is a formal announcement under the Hong Kong Securities and Futures Ordinance and Listing Rule 13.09 regarding the execution of a subscription agreement for issuing RMB6,780 million zero‐coupon USD-settled convertible bonds due 2027. It details the terms and conditions of the bond issuance, use of proceeds, conversion price, listing applications, and all relevant financing structures. There is no actual financial statement data but a detailed outline of a capital-raising transaction. This clearly falls under a Capital/Financing Update.
2026-05-15 Chinese
关于拟发行人民币67.8亿元于2027年到期之美元结算零息可转换债券的公告
Capital/Financing Update Classification · 95% confidence The document is an official board announcement detailing the proposed issuance of RMB 67.8 billion zero‐coupon convertible bonds due 2027, including terms, pricing, conversion mechanics, use of proceeds, and regulatory approvals. This clearly relates to a company fundraising and financing activity rather than a report publication, earnings release, or management discussion. Therefore, it fits the Capital/Financing Update category.
2026-05-14 Chinese

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.